Showing results (111-120 of 2,750) with videos related to
Sort By:
Pageof 275
Life Sciences|January 1, 1989
Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjectsP L Delgado, D S Charney, L H Price, et al.Biological Psychiatry|May 1, 1997
Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjectsL C Barr, G R Heninger, W Goodman, et al.The American Journal of Drug and Alcohol Abuse|January 1, 1992
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?J H Krystal, L H Price, C Opsahl, et al.Archives of General Psychiatry|August 2, 2000
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorderC J McDougle, C N Epperson, G H Pelton, et al.The Journal of Clinical Psychiatry|March 13, 1999
Mirtazapine augmentation in the treatment of refractory depressionL L Carpenter, Z Jocic, J M Hall, et al.Journal of Child and Adolescent Psychopharmacology|July 1, 1997
Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigationE S Brodkin, C J McDougle, S T Naylor, et al.Journal of Clinical Psychopharmacology|February 24, 1998
Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotoninM Narayan, G Anderson, J Cellar, et al.The American Journal of Psychiatry|August 1, 1987
Treatment of severe obsessive-compulsive disorder with fluvoxamineL H Price, W K Goodman, D S Charney, et al.The Journal of Clinical Psychiatry|June 1, 1993
Biological approaches to treatment-resistant obsessive compulsive disorderW K Goodman, C J McDougle, L C Barr, et al.Acta Psychiatrica Scandinavica|May 14, 2013
The neurobiological correlates of childhood adversity and implications for treatmentA R Tyrka, D E Burgers, N S Philip, et al.Pageof 275